Clinical profile and outcome of pediatric neurocysticercosis: A study from Western Nepal

Journal of Pediatric Neurology

Volumn 5, Issue 1, 2007, Pages 45-52

  Basu, Sriparna ^a,b   Ramchandran, Uma ^a   Thapliyal, Anna ^a  

^a MANIPAL TEACHING HOSPITAL   (Nepal)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Children; Nepal; Neurocysticercosis; Seizure

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DEXAMETHASONE; MANNITOL; MIDAZOLAM; PHENYTOIN; PREDNISOLONE;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; BRAIN EDEMA; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HUMAN; INFANT; INTRACRANIAL HYPERTENSION; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGOENCEPHALITIS; NEPAL; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; OPHTHALMOPLEGIA; PARIETAL LOBE; PROGNOSIS; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 33847778230     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. N.A. Mafojane, C.C. Appleton, R.C. Krecek, L.M. Michael and A.L. Willingham 3rd, The current status of neurocysticercosis in Eastern and Southern Africa, Acta Trop 87 (2003), 25-33.
2. V. Rajshekhar, D.D. Joshi, N.Q. Doanh, N. van De and Z. Xiaonong, Taenia solium taemosis/cysticercosis in Asia: Epidemiology, impact and issues, Acta Trop 87 (2003), 53-60.
3. H.H. Garcia, A.E. Gonzalez, C.A. Evans and R.H. Gilman, Cysticercosis Working Group in Peru. Taenia solium cysticercosis, Lancet 362 (2003), 547-556.
4. A. Carpio, M. Placencia, F. Santillan and A. Escobar, A proposal for classification of neurocysticercosis, Can J Neurol Sci 21 (1994), 43-47.
5. J.E. Silva, A.P. Diefenthaler and J.K. Palma, Frequency of suspected cases of neurocysticercosis detected by computed skull tomography in Santa Maria, RS, Brazil, Rev Inst Med Trop Sao Paulo 42 (2000), 57-58.
6. A. Ito, M. Nakao and T. Wandra, Human taeniasis and cysticercosis in Asia, Lancet 362 (2003), 1918-1920.
7. B. Talukdar, A. Saxena, V.K. Popli and V. Choudhury, Neurocysticercosis in children: Clinical characteristics and outcome, Ann Trop Paediatr 22 (2002), 333-339.
8. P. Singhi, M. Ray, S. Singlu and N. Khandelwal, Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy, J Child Neurol 15 (2000), 207-213.
9. M.G. das Chagas, A. D'Oliveira Junior and J. Tavares-Neto, Clinical aspects of neurocysticercosis at semi-desert region of Brazilian northeast, Arq Neuropsiquiatr 61 (2003), 398-402, (in Portuguese).
10. N.M. Morales, S. Agapejev, R.R. Morales, N.A. Padula and M.M. Lima, Clinical aspects of neurocysticercosis in children, Pediatr Neurol 22 (2000), 287-291.
11. S. Terraza, T. Pujol, J. Gascon and M. Corachan, Neurocysticercosis: An imported disease? Med Clin (Barc) 116 (2001), 261-263, (in Spanish).
12. F. Wiegand, S. Koeppen, P. Haussermann and A. Delcker, Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases, Nervenarzt 70 (1999), 298-305, (in German).
13. I.C. Santos, E. Kobayashi, T.M. Cardoso, C.A. Guerreiro and F. Cendes, Cysticidal therapy: Impact on seizure control in epilepsy associated with neurocysticercosis, Arq Neuropsiquiatr 58 (2000), 1014-1020.
14. S. Rajadhyaksha, K.N. Shah, S. Kanhere, N. Naik and R. Mehta, Does treatment change the outcome of seizures and computerized tomographic lesions in intracranial granulomas? J Trop Pediatr 45 (1999), 161-165.
15. A. Carpio and W.A. Hauser, Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis, Neurology 59 (2002), 1730-1734.
16. H.H. Garcia, E.J. Pretell, R.H. Gilman et al., Cysticercosis Working Group in Peru. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis, N Engl J Med 350 (2004), 249-258.
17. A.K. Baranwal, P.D. Singhi, N. Khandelwal and S.C. Singhi, Morphometry of single small enhancing computed tomographic lesions: Outcome and effect of albendazole therapy, J Trop Pediatr 48 (2002), 219-224.
18. H.H. Garcia, R.H. Gilman, J. Horton et al., Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru, Neurology 48 (1997), 1421-1427.
19. P. Singhi, D. Dayal and N. Khandelwal, One week versus four weeks of albendazole therapy for neurocysticercosis in children: A randomized, placebo-controlled double blind trial, Pediatr Infect Dis J 22 (2003), 268-272.
20. R. Blanton, Cysticercosis, in: Nelson Textbook of Pediatrics, (17th ed.), R.E. Behrman, R.M. Kliegman and H.B. Jenson, eds, Philadelphia: Saunders, 2004, pp. 1171-1172.
21. V. Kalra, T. Dua and V. Kumar, Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial, J Pediatr 143 (2003), 111-114.
22. J.V. Proano, I. Madrazo, F. Avelar, B. Lopez-Felix, G. Diaz and I. Grijalva, Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts, N Engl J Med 345 (2001), 879-885.